Insider · CIK 0001741533

Paolini John F.

Reports to the SEC for 1 company · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001741533

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+2,497 sh	—	—	68,120
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+1,624 sh	—	—	69,744
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+1,750 sh	—	—	71,494
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+2,457 sh	—	—	73,951
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcF Tax Payment	CHIEF MEDICAL OFFICER	FTax Payment	−4,029 sh	$79.28	−$319K	69,922
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitA Award	CHIEF MEDICAL OFFICER	AAward	+6,700 sh	—	—	6,700
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	CHIEF MEDICAL OFFICER	AAward	+26.8K sh	—	—	26,750
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−2,457 sh	—	—	7,371
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−1,750 sh	—	—	3,500
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−1,624 sh	—	—	1,624
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−2,497 sh	—	—	0
2026-05-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+58.4K sh	$10.36	+$605K	124,047
2026-05-01	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF MEDICAL OFFICER	SSale	−37.3K sh	$53.52	−$2M	86,720
2026-05-01	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF MEDICAL OFFICER	SSale	−21.1K sh	$54.04	−$1.14M	65,623
2026-05-01	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−58.4K sh	—	—	29,670
2026-04-07	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+2,497 sh	—	—	66,831
2026-04-07	KNSAKiniksa Pharmaceuticals International, plcF Tax Payment	CHIEF MEDICAL OFFICER	FTax Payment	−1,208 sh	$48.94	−$59.1K	65,623
2026-04-07	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−2,497 sh	—	—	0
2026-04-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+5,831 sh	—	—	67,155
2026-04-01	KNSAKiniksa Pharmaceuticals International, plcF Tax Payment	CHIEF MEDICAL OFFICER	FTax Payment	−2,821 sh	$48.13	−$136K	64,334
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	CHIEF MEDICAL OFFICER	AAward	+26.8K sh	—	—	26,750
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitA Award	CHIEF MEDICAL OFFICER	AAward	+6,700 sh	—	—	6,700
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Performance Share UnitA Award	CHIEF MEDICAL OFFICER	AAward	+13.4K sh	—	—	13,400
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−1,624 sh	—	—	1,624
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−1,750 sh	—	—	3,500
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−2,457 sh	—	—	7,371
2026-03-02	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+40K sh	$10.36	+$414K	101,324
2026-03-02	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF MEDICAL OFFICER	SSale	−12.1K sh	$44.20	−$533K	89,261
2026-03-02	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF MEDICAL OFFICER	SSale	−22.2K sh	$44.88	−$997K	67,038
2026-03-02	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF MEDICAL OFFICER	SSale	−5,714 sh	$45.92	−$262K	61,324
2026-03-02	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−40K sh	—	—	58,424
2025-10-31	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+36.5K sh	$3.80	+$139K	97,866
2025-10-31	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+46K sh	$8.83	+$406K	143,866
2025-10-31	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF MEDICAL OFFICER	SSale	−82.5K sh	$37.14	−$3.07M	61,324
2025-10-31	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−36.5K sh	—	—	0
2025-10-31	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−46K sh	—	—	0
2025-09-02	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+1,725 sh	—	—	62,159
2025-09-02	KNSAKiniksa Pharmaceuticals International, plcF Tax Payment	CHIEF MEDICAL OFFICER	FTax Payment	−835 sh	$34.28	−$28.6K	61,324
2025-09-02	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−1,725 sh	—	—	0
2025-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+1,750 sh	—	—	59,153
2025-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+1,624 sh	—	—	60,777
2025-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+2,498 sh	—	—	63,275
2025-09-01	KNSAKiniksa Pharmaceuticals International, plcF Tax Payment	CHIEF MEDICAL OFFICER	FTax Payment	−2,841 sh	$33.49	−$95.1K	60,434
2025-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitA Award	CHIEF MEDICAL OFFICER	AAward	+9,828 sh	—	—	9,828
2025-09-01	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	CHIEF MEDICAL OFFICER	AAward	+39.4K sh	—	—	39,364
2025-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−1,750 sh	—	—	5,250
2025-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−1,624 sh	—	—	3,248
2025-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−2,498 sh	—	—	2,497
2025-08-06	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+29.3K sh	$3.80	+$111K	86,728
2025-08-06	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF MEDICAL OFFICER	SSale	−29.3K sh	$32.55	−$955K	57,403

Recent filings

Accepted (ET)
Sep 34
Paolini John F.0001741533-26-000010
SEC(opens sec.gov)
May 54
Paolini John F.0001741533-26-000008
SEC(opens sec.gov)
Apr 84
Paolini John F.0001741533-26-000006
SEC(opens sec.gov)
Apr 34
Paolini John F.0001741533-26-000004
SEC(opens sec.gov)

Companies

Kiniksa Pharmaceuticals International, plcCHIEF MEDICAL OFFICERKNSA

Address

C/O KINIKSA PHARMACEUTICALS INT'L 105 PICCADILLY, SECOND FLOOR

LONDON, W1J 7NJ